{"transactions":[{"id":692991,"issuer":{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25416,"kind":"organization","name":"Redmile Biopharma Investments III, L.P.","position":3,"cik":"0001838746","reported_name":"Redmile Biopharma Investments III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-08-08T01:47:17.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":782854,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 6, 2026, the Series B Preferred Stock converted by its terms in full automatically into shares of the Issuer's common stock, upon the consummation of the Issuer's initial public offering (\"IPO\"), for no consideration. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 6, 2026, the Series B Preferred Stock converted by its terms in full automatically into shares of the Issuer's common stock, upon the consummation of the Issuer's initial public offering (\"IPO\"), for no consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 6, 2026, the Series B Preferred Stock converted by its terms in full automatically into shares of the Issuer's common stock, upon the consummation of the Issuer's initial public offering (\"IPO\"), for no consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 6, 2026, the Series B Preferred Stock converted by its terms in full automatically into shares of the Issuer's common stock, upon the consummation of the Issuer's initial public offering (\"IPO\"), for no consideration. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Redmile Biopharma Investments III, L.P. (\"RBI III\"), which is managed by Redmile Group, LLC (\"Redmile\"). RBI III disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that RBI III is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RBI III and the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":782854},"source":{"system":"sec-edgar","filing":"0001104659-26-092867","document":"tm2622627-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926092867/tm2622627-1_4seq1.xml","form_type":"4"}},{"id":692990,"issuer":{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25416,"kind":"organization","name":"Redmile Biopharma Investments III, L.P.","position":3,"cik":"0001838746","reported_name":"Redmile Biopharma Investments III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-08T01:47:17.000Z","date":"2026-08-06","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":17,"value":6800000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities were purchased in the IPO by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), and include the number of securities purchased by RBI III in the IPO reported in the line above."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RBI III and the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":1182854,"source":{"system":"sec-edgar","filing":"0001104659-26-092867","document":"tm2622627-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926092867/tm2622627-1_4seq1.xml","form_type":"4"}},{"id":692989,"issuer":{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25416,"kind":"organization","name":"Redmile Biopharma Investments III, L.P.","position":3,"cik":"0001838746","reported_name":"Redmile Biopharma Investments III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-08T01:47:17.000Z","date":"2026-08-06","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":17,"value":3400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Redmile Biopharma Investments III, L.P. (\"RBI III\"), which is managed by Redmile Group, LLC (\"Redmile\"). RBI III disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that RBI III is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RBI III and the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":982854,"source":{"system":"sec-edgar","filing":"0001104659-26-092867","document":"tm2622627-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926092867/tm2622627-1_4seq1.xml","form_type":"4"}},{"id":692988,"issuer":{"id":4984,"kind":"organization","name":"Attovia Therapeutics, Inc.","symbol":"ATTO"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25416,"kind":"organization","name":"Redmile Biopharma Investments III, L.P.","position":3,"cik":"0001838746","reported_name":"Redmile Biopharma Investments III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-08T01:47:17.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":782854,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 6, 2026, the Series B Preferred Stock converted by its terms in full automatically into shares of the Issuer's common stock, upon the consummation of the Issuer's initial public offering (\"IPO\"), for no consideration. The Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Redmile Biopharma Investments III, L.P. (\"RBI III\"), which is managed by Redmile Group, LLC (\"Redmile\"). RBI III disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that RBI III is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RBI III and the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":782854,"source":{"system":"sec-edgar","filing":"0001104659-26-092867","document":"tm2622627-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926092867/tm2622627-1_4seq1.xml","form_type":"4"}},{"id":703475,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2026-07-25T01:00:10.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":55387,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on December 11, 2020 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on December 11, 2020 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on December 11, 2020 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private funds managed by Redmile Group, LLC (collectively, the \"Funds\") and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as investment manager of the Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.0025,"underlying":"Common Stock","underlying_shares":55387},"source":{"system":"sec-edgar","filing":"0001104659-26-086733","document":"tm2621190-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926086733/tm2621190-2_4seq1.xml","form_type":"4"}},{"id":703474,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2026-07-25T01:00:10.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":38735,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on May 29, 2020 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on May 29, 2020 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on May 29, 2020 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private funds managed by Redmile Group, LLC (collectively, the \"Funds\") and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as investment manager of the Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.0025,"underlying":"Common Stock","underlying_shares":38735},"source":{"system":"sec-edgar","filing":"0001104659-26-086733","document":"tm2621190-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926086733/tm2621190-2_4seq1.xml","form_type":"4"}},{"id":703473,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2026-07-25T01:00:10.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":101089,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on July 23, 2019 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on July 23, 2019 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Pre-Funded Warrants are exercisable at any time on or after the original issuance on July 23, 2019 until the seven-year anniversary of the original issuance date, at an exercise price equal to $0.0025 per share, subject to a 9.99% beneficial ownership blocker."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The previous report on Form 3 inadvertently indicated that all of the Pre-Funded Warrants beneficially owned by the Reporting Persons have an exercise price of $0.0001 per share and no expiration date. Footnotes (1), (2), (3), (6) and (7) and the related disclosures correct the Form 3 with respect to the terms of the Pre-Funded Warrants beneficially owned by the Reporting Persons."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private funds managed by Redmile Group, LLC (collectively, the \"Funds\") and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as investment manager of the Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.0025,"underlying":"Common Stock","underlying_shares":101089},"source":{"system":"sec-edgar","filing":"0001104659-26-086733","document":"tm2621190-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926086733/tm2621190-2_4seq1.xml","form_type":"4"}},{"id":703472,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-25T01:00:10.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":60,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private funds managed by Redmile Group, LLC (collectively, the \"Funds\") and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as investment manager of the Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":636852,"source":{"system":"sec-edgar","filing":"0001104659-26-086733","document":"tm2621190-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926086733/tm2621190-2_4seq1.xml","form_type":"4"}},{"id":703471,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-25T01:00:10.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":195211,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 22, 2026, the Reporting Persons exercised the reported Pre-Funded Warrants through a \"cashless exercise\" resulting in the Issuer withholding 60 shares of Common Stock to pay the exercise price and issuing the remaining 195,151 shares of Common Stock to the applicable Funds. The number of shares withheld to pay the aggregate exercise price for the cashless exercise of the Pre-Funded Warrants was based on the closing sale price per share of the Common Stock on the trading date immediately prior to the exercise date, per the terms of the Pre-Funded Warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private funds managed by Redmile Group, LLC (collectively, the \"Funds\") and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as investment manager of the Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":636912,"source":{"system":"sec-edgar","filing":"0001104659-26-086733","document":"tm2621190-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926086733/tm2621190-2_4seq1.xml","form_type":"4"}},{"id":737705,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T21:16:22.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":87900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in full and become exercisable upon the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to Michael Lee's continued service on the board of directors of the Issuer through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The stock option award was granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the board of directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this equity award as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the equity award to Redmile. Mr. Lee disclaims beneficial ownership of the equity award, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The stock option award may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the equity award except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":87900,"derivative":{"exercise_price":2.06,"expiration_date":"2036-06-12","underlying":"Common Stock","underlying_shares":87900},"source":{"system":"sec-edgar","filing":"0001104659-26-074130","document":"tm2617974-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926074130/tm2617974-2_4seq1.xml","form_type":"4"}},{"id":801777,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2026-04-24T01:00:13.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":266280,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the reference price associated with the swap agreements. On April 22, 2026, the Reporting Persons filed a Form 4 that inadvertently misstated the reference price associated with the swap agreements novated by RedCo II Master Fund, L.P. (\"RedCo II\") to its two wholly-owned subsidiaries (collectively, the \"SPVs\") in the internal reorganization reported on the prior Form 4. This amendment is being filed solely to correct this administrative error and include the correct reference price."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is reported to reflect that two of the Reporting Persons (Redmile and Jeremy Green, its principal) retain an indirect beneficial ownership in the securities transacted in, as reported in the row above. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"kind","element":"transactionCoding","label":"F7","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Certain Redmile Clients are parties to swap agreements with counterparties. Each notional share subject to each swap agreement represents the economic equivalent of one share of Common Stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Redmile Clients that are parties to the swap agreements have the right to close out each swap at any time. Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":502769,"derivative":{"exercise_price":5.84,"underlying":"Common Stock","underlying_shares":266280},"source":{"system":"sec-edgar","filing":"0001104659-26-047974","document":"tm2612608-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047974/tm2612608-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-04-22"}},{"id":801776,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2026-04-24T01:00:13.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":266280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the reference price associated with the swap agreements. On April 22, 2026, the Reporting Persons filed a Form 4 that inadvertently misstated the reference price associated with the swap agreements novated by RedCo II Master Fund, L.P. (\"RedCo II\") to its two wholly-owned subsidiaries (collectively, the \"SPVs\") in the internal reorganization reported on the prior Form 4. This amendment is being filed solely to correct this administrative error and include the correct reference price."},{"field":"kind","element":"transactionCoding","label":"F7","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Certain Redmile Clients are parties to swap agreements with counterparties. Each notional share subject to each swap agreement represents the economic equivalent of one share of Common Stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Redmile Clients that are parties to the swap agreements have the right to close out each swap at any time. Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities were directly owned by RedCo II, a private investment vehicle managed by Redmile Group, LLC (\"Redmile\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":5.84,"underlying":"Common Stock","underlying_shares":266280},"source":{"system":"sec-edgar","filing":"0001104659-26-047974","document":"tm2612608-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047974/tm2612608-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-04-22"}},{"id":802672,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Convertible Preferred Stock","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":162013,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"The Class A Preferred Stock is convertible into Common Stock, in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The one-for-five conversion rate is taken into account in the amount of underlying Common Stock involved in the transaction listed under Column 7 of Table II."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is reported to reflect that two of the Reporting Persons (Redmile and Jeremy Green, its principal) retain an indirect beneficial ownership in the securities transacted in, as reported in the row above. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Class A Preferred Stock is convertible into Common Stock, in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F13","text":"The one-for-five conversion rate is taken into account in the amount of underlying Common Stock involved in the transaction listed under Column 7 of Table II."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":2755086,"derivative":{"underlying":"Common Stock","underlying_shares":810065},"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802671,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Convertible Preferred Stock","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":162013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"The Class A Preferred Stock is convertible into Common Stock, in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The one-for-five conversion rate is taken into account in the amount of underlying Common Stock involved in the transaction listed under Column 7 of Table II."},{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The Class A Preferred Stock is convertible into Common Stock, in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F13","text":"The one-for-five conversion rate is taken into account in the amount of underlying Common Stock involved in the transaction listed under Column 7 of Table II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities were directly owned by RedCo II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":810065},"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802670,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":266280,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Represents the reference price associated with the swap agreements."},{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is reported to reflect that two of the Reporting Persons (Redmile and Jeremy Green, its principal) retain an indirect beneficial ownership in the securities transacted in, as reported in the row above. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Certain Redmile Clients are parties to swap agreements with counterparties. Each notional share subject to each swap agreement represents the economic equivalent of one share of Common Stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Redmile Clients that are parties to the swap agreements have the right to close out each swap at any time. Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":502769,"derivative":{"exercise_price":3.02,"underlying":"Common Stock","underlying_shares":266280},"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802669,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":266280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Represents the reference price associated with the swap agreements."},{"field":"kind","element":"transactionCoding","label":"F9","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"In connection with the reorganization of RedCo II, the swap agreements to which RedCo II was a counterparty were novated to the SPVs on a pro-rata basis, for no consideration, with no change to any other terms of the swap agreement and no change in the economic exposure."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Certain Redmile Clients are parties to swap agreements with counterparties. Each notional share subject to each swap agreement represents the economic equivalent of one share of Common Stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The Redmile Clients that are parties to the swap agreements have the right to close out each swap at any time. Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities were directly owned by RedCo II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":3.02,"underlying":"Common Stock","underlying_shares":266280},"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802668,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":3691324,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is reported to reflect that two of the Reporting Persons (Redmile and Jeremy Green, its principal) retain an indirect beneficial ownership in the securities transacted in, as reported in the row above. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The pre-funded warrants (\"Warrants\") are exercisable by the holder at any time until fully exercised at an exercise price per share of $0.001, subject to a limitation on the right of the Issuer to issue Common Stock if and to the extent that such exercise would cause the holder and its affiliates to beneficially own in the aggregate more than 14.99% of the combined voting power of all of the securities of the Issuer outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Warrants have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The pre-funded warrants (\"Warrants\") are exercisable by the holder at any time until fully exercised at an exercise price per share of $0.001, subject to a limitation on the right of the Issuer to issue Common Stock if and to the extent that such exercise would cause the holder and its affiliates to beneficially own in the aggregate more than 14.99% of the combined voting power of all of the securities of the Issuer outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Warrants have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":3893674,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":3691324},"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802667,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":3691324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The pre-funded warrants (\"Warrants\") are exercisable by the holder at any time until fully exercised at an exercise price per share of $0.001, subject to a limitation on the right of the Issuer to issue Common Stock if and to the extent that such exercise would cause the holder and its affiliates to beneficially own in the aggregate more than 14.99% of the combined voting power of all of the securities of the Issuer outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Warrants have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The pre-funded warrants (\"Warrants\") are exercisable by the holder at any time until fully exercised at an exercise price per share of $0.001, subject to a limitation on the right of the Issuer to issue Common Stock if and to the extent that such exercise would cause the holder and its affiliates to beneficially own in the aggregate more than 14.99% of the combined voting power of all of the securities of the Issuer outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Warrants have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities were directly owned by RedCo II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":3691324},"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802666,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":true,"shares":8977624,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction is reported to reflect that two of the Reporting Persons (Redmile and Jeremy Green, its principal) retain an indirect beneficial ownership in the securities transacted in, as reported in the row above. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are directly owned by certain private investment vehicles managed by Redmile (collectively, the \"Redmile Clients\"), excluding RedCo II but including the SPVs."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":12884277,"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":802665,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-23T01:51:32.000Z","date":"2026-04-20","kind":"other","planned":false,"acquired":false,"shares":8977624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with an internal reorganization of RedCo II Master Fund, L.P. (\"RedCo II\"), which is one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), the reported securities were distributed pro rata and in kind, for no consideration, by RedCo II to its two wholly-owned subsidiaries (collectively, the \"SPVs\"), which are also managed by Redmile. As a result, RedCo II no longer has voting or dispositive power over such securities and is no longer a beneficial owner of more than 10% of the Issuer's Common Stock, par value $0.001 per share (the \"Common Stock\"), and will be dissolved. Accordingly, this Form 4 serves as an exit filing for RedCo II. The internal reorganization resulted in no change in the aggregate beneficial ownership of Redmile or Mr. Green."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities were directly owned by RedCo II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of RedCo II, each of the SPVs, and each of the other Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-047072","document":"tm2612392-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465926047072/tm2612392-1_4seq1.xml","form_type":"4"}},{"id":819353,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T01:00:23.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":2529491,"price":3.279,"value":8294200.989,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.77, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly owned by RedCo II Master Fund, L.P."}],"balance_after":10265297,"source":{"system":"sec-edgar","filing":"0001104659-26-039359","document":"tm2611043-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926039359/tm2611043-1_4seq1.xml","form_type":"4"}},{"id":819352,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T01:00:23.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":2634506,"price":3.279,"value":8638545.174,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.25 to $3.77, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P., and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":12666731,"source":{"system":"sec-edgar","filing":"0001104659-26-039359","document":"tm2611043-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926039359/tm2611043-1_4seq1.xml","form_type":"4"}},{"id":819351,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T01:00:23.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":162517,"price":3.799,"value":617402.083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.83, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly owned by RedCo II Master Fund, L.P."}],"balance_after":12794788,"source":{"system":"sec-edgar","filing":"0001104659-26-039359","document":"tm2611043-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926039359/tm2611043-1_4seq1.xml","form_type":"4"}},{"id":819350,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T01:00:23.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":169265,"price":3.799,"value":643037.735,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.83, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P., and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":15301237,"source":{"system":"sec-edgar","filing":"0001104659-26-039359","document":"tm2611043-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926039359/tm2611043-1_4seq1.xml","form_type":"4"}},{"id":819349,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T01:00:23.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":188407,"price":3.752,"value":706903.064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.63 to $3.81, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are directly owned by RedCo II Master Fund, L.P."}],"balance_after":12957305,"source":{"system":"sec-edgar","filing":"0001104659-26-039359","document":"tm2611043-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926039359/tm2611043-1_4seq1.xml","form_type":"4"}},{"id":819348,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T01:00:23.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":196229,"price":3.752,"value":736251.208,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.63 to $3.81, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P., and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or for any other purpose."}],"balance_after":15470502,"source":{"system":"sec-edgar","filing":"0001104659-26-039359","document":"tm2611043-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465926039359/tm2611043-1_4seq1.xml","form_type":"4"}},{"id":1012543,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2025-10-29T01:00:10.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":3846153,"price":3.9,"value":14999996.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the October 12, 2025 exchange rate of approximately $1.25 to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of October 12, 2025 was approximately $0.10."},{"field":"kind","element":"transactionCoding","label":"F1","text":"RedCo II Master Fund, L.P. (\"RedCo II\") acquired the reported pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\") in a private placement by the Issuer pursuant to the terms of a securities purchase agreement, dated October 12, 2025 (the \"Purchase Agreement\"), by and among the Issuer and RedCo II. The purchase price per Pre-Funded Warrants is $3.90, which is the price per Common Share in the private placement minus the exercise price per Pre-Funded Warrant. The closing of the private placement occurred on October 27, 2025 following the satisfaction of the closing conditions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable by the holder at any time on or after the closing date of the private placement until the tenth anniversary of such closing date, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre-Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These reported securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed in the row above to disclose this fund's direct ownership."}],"balance_after":3846153,"derivative":{"exercise_date":"2025-10-27","underlying":"Common Share","underlying_shares":3846153},"source":{"system":"sec-edgar","filing":"0001104659-25-103336","document":"tm2529454-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925103336/tm2529454-1_4seq1.xml","form_type":"4"}},{"id":1012542,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2025-10-29T01:00:10.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":3846153,"price":3.9,"value":14999996.7,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the October 12, 2025 exchange rate of approximately $1.25 to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of October 12, 2025 was approximately $0.10."},{"field":"kind","element":"transactionCoding","label":"F1","text":"RedCo II Master Fund, L.P. (\"RedCo II\") acquired the reported pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\") in a private placement by the Issuer pursuant to the terms of a securities purchase agreement, dated October 12, 2025 (the \"Purchase Agreement\"), by and among the Issuer and RedCo II. The purchase price per Pre-Funded Warrants is $3.90, which is the price per Common Share in the private placement minus the exercise price per Pre-Funded Warrant. The closing of the private placement occurred on October 27, 2025 following the satisfaction of the closing conditions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable by the holder at any time on or after the closing date of the private placement until the tenth anniversary of such closing date, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre-Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These reported securities are directly owned by RedCo II. Redmile Group, LLC (\"Redmile\") may be deemed to beneficially own the reported securities as the investment manager of RedCo II. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3846153,"derivative":{"exercise_date":"2025-10-27","underlying":"Common Share","underlying_shares":3846153},"source":{"system":"sec-edgar","filing":"0001104659-25-103336","document":"tm2529454-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925103336/tm2529454-1_4seq1.xml","form_type":"4"}},{"id":1055599,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Warrants to Purchase Common Stock","published_at":"2025-08-26T21:00:29.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":4097730,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 25, 2025 (the \"Closing Date\"), pursuant to the terms of that certain securities purchase agreement, dated as of August 4, 2025 (the \"Purchase Agreement\") and following the satisfaction of certain material conditions set forth therein, the Issuer issued and sold to certain institutional investors in a private placement, including certain private investment vehicles managed by Redmile Group, LLC (the \"Redmile Clients\"), pre-funded warrants (the \"Pre-Funded Warrants\") to purchase shares of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\"), accompanied by warrants (the \"Common Warrants\") to purchase an equal number of shares of Common Stock (or, in lieu thereof, Pre-Funded Warrants to purchase up to the same number of shares), at a combined purchase price for both securities of $0.8676."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Pre-Funded Warrants and Common Warrants are exercisable by the holder at any time on or after the Closing Date, subject to a 9.99% beneficial ownership blocker. The Pre-Funded Warrants do not have an expiration date. The Common Warrants will expire 30 days after a public announcement of the data from the Issuer's Phase 1 clinical trial for SL-325 in healthy volunteers and the design of its Phase 2 clinical trial."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants and Common Warrants are exercisable by the holder at any time on or after the Closing Date, subject to a 9.99% beneficial ownership blocker. The Pre-Funded Warrants do not have an expiration date. The Common Warrants will expire 30 days after a public announcement of the data from the Issuer's Phase 1 clinical trial for SL-325 in healthy volunteers and the design of its Phase 2 clinical trial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly owned by the Redmile Clients, and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as the investment manager of the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":4097730,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":4097730},"source":{"system":"sec-edgar","filing":"0001104659-25-083134","document":"tm2524352-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925083134/tm2524352-2_4seq1.xml","form_type":"4"}},{"id":1055598,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2025-08-26T21:00:29.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":4097730,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 25, 2025 (the \"Closing Date\"), pursuant to the terms of that certain securities purchase agreement, dated as of August 4, 2025 (the \"Purchase Agreement\") and following the satisfaction of certain material conditions set forth therein, the Issuer issued and sold to certain institutional investors in a private placement, including certain private investment vehicles managed by Redmile Group, LLC (the \"Redmile Clients\"), pre-funded warrants (the \"Pre-Funded Warrants\") to purchase shares of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\"), accompanied by warrants (the \"Common Warrants\") to purchase an equal number of shares of Common Stock (or, in lieu thereof, Pre-Funded Warrants to purchase up to the same number of shares), at a combined purchase price for both securities of $0.8676."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Pre-Funded Warrants and Common Warrants are exercisable by the holder at any time on or after the Closing Date, subject to a 9.99% beneficial ownership blocker. The Pre-Funded Warrants do not have an expiration date. The Common Warrants will expire 30 days after a public announcement of the data from the Issuer's Phase 1 clinical trial for SL-325 in healthy volunteers and the design of its Phase 2 clinical trial."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants and Common Warrants are exercisable by the holder at any time on or after the Closing Date, subject to a 9.99% beneficial ownership blocker. The Pre-Funded Warrants do not have an expiration date. The Common Warrants will expire 30 days after a public announcement of the data from the Issuer's Phase 1 clinical trial for SL-325 in healthy volunteers and the design of its Phase 2 clinical trial."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities are directly owned by the Redmile Clients, and may be deemed beneficially owned by Redmile Group, LLC (\"Redmile\") as the investment manager of the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":7198553,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":4097730},"source":{"system":"sec-edgar","filing":"0001104659-25-083134","document":"tm2524352-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925083134/tm2524352-2_4seq1.xml","form_type":"4"}},{"id":1065274,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2025-08-15T17:00:13.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667666,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On August 14, 2025, the Issuer completed its merger transaction with and into Merger Sub pursuant to the terms of the Merger Agreement, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective date and time of the Merger (the \"Merger Closing\"), each outstanding and unexercised pre-funded warrant to purchase shares of the Issuer's Common Stock (each, a \"Pre-Funded Warrant\") was cancelled and the holder received the right to a cash amount based on the Offer Price, subject to applicable tax withholding and without interest, less the exercise price per share underlying the Pre-Funded Warrant, plus one CVR per underlying share subject to the terms and conditions of a CVR Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 14, 2025, the Issuer completed its merger transaction with and into Merger Sub pursuant to the terms of the Merger Agreement, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). At the effective date and time of the Merger (the \"Merger Closing\"), each outstanding and unexercised pre-funded warrant to purchase shares of the Issuer's Common Stock (each, a \"Pre-Funded Warrant\") was cancelled and the holder received the right to a cash amount based on the Offer Price, subject to applicable tax withholding and without interest, less the exercise price per share underlying the Pre-Funded Warrant, plus one CVR per underlying share subject to the terms and conditions of a CVR Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants to purchase common stock of the Issuer have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Common Stock, Non-Voting Common Stock, and Pre-Funded Warrants of the Issuer reported herein were directly owned by certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may have been deemed beneficially owned by Redmile as investment manager of the Redmile Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.01,"exercise_date":"2020-12-11","underlying":"Common Stock","underlying_shares":667666},"source":{"system":"sec-edgar","filing":"0001104659-25-079307","document":"tm2523477-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465925079307/tm2523477-3_4seq1.xml","form_type":"4"}},{"id":1065273,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Voting Common Stock","published_at":"2025-08-15T17:00:13.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7199325,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Non-Voting Common Stock was convertible into shares of the Issuer's common stock at any time, in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation at any time and from time to time at the holder's election on a 1-for-1 basis. The Non-Voting Common Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"On August 14, 2025, pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 1, 2025, among the Issuer, Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer to purchase all outstanding shares of the Issuer's Common Stock and Non-Voting Common Stock (\"Issuer Shares\") in exchange for (a) a price per share of $1.247 in cash (the \"Offer Price\"), subject to applicable tax withholding and without interest, plus (b) one contingent value right (\"CVR\") per share subject to the terms and conditions of a Contingent Value Rights Agreement (\"CVR Agreement\"). The tender offer expired one minute following 11:59 p.m., Eastern Time, on August 13, 2025 (the \"Offer Closing\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 14, 2025, pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 1, 2025, among the Issuer, Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer to purchase all outstanding shares of the Issuer's Common Stock and Non-Voting Common Stock (\"Issuer Shares\") in exchange for (a) a price per share of $1.247 in cash (the \"Offer Price\"), subject to applicable tax withholding and without interest, plus (b) one contingent value right (\"CVR\") per share subject to the terms and conditions of a Contingent Value Rights Agreement (\"CVR Agreement\"). The tender offer expired one minute following 11:59 p.m., Eastern Time, on August 13, 2025 (the \"Offer Closing\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Non-Voting Common Stock was convertible into shares of the Issuer's common stock at any time, in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation at any time and from time to time at the holder's election on a 1-for-1 basis. The Non-Voting Common Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Non-Voting Common Stock was convertible into shares of the Issuer's common stock at any time, in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation at any time and from time to time at the holder's election on a 1-for-1 basis. The Non-Voting Common Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Common Stock, Non-Voting Common Stock, and Pre-Funded Warrants of the Issuer reported herein were directly owned by certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may have been deemed beneficially owned by Redmile as investment manager of the Redmile Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7199325},"source":{"system":"sec-edgar","filing":"0001104659-25-079307","document":"tm2523477-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465925079307/tm2523477-3_4seq1.xml","form_type":"4"}},{"id":1065272,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T17:00:13.000Z","date":"2025-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2964843,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 14, 2025, pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of July 1, 2025, among the Issuer, Concentra Biosciences, LLC, a Delaware limited liability company (\"Parent\"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer to purchase all outstanding shares of the Issuer's Common Stock and Non-Voting Common Stock (\"Issuer Shares\") in exchange for (a) a price per share of $1.247 in cash (the \"Offer Price\"), subject to applicable tax withholding and without interest, plus (b) one contingent value right (\"CVR\") per share subject to the terms and conditions of a Contingent Value Rights Agreement (\"CVR Agreement\"). The tender offer expired one minute following 11:59 p.m., Eastern Time, on August 13, 2025 (the \"Offer Closing\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Common Stock, Non-Voting Common Stock, and Pre-Funded Warrants of the Issuer reported herein were directly owned by certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may have been deemed beneficially owned by Redmile as investment manager of the Redmile Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-079307","document":"tm2523477-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465925079307/tm2523477-3_4seq1.xml","form_type":"4"}},{"id":1086459,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-17T01:00:22.000Z","date":"2025-07-14","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) immediately prior to the next annual meeting of the Issuer's shareholders, subject to Mr. Michael Lee's continued service to the Issuer through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":33150,"derivative":{"exercise_price":0.82,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0001104659-25-068453","document":"tm2521022-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925068453/tm2521022-1_4seq1.xml","form_type":"4"}},{"id":1095107,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T16:01:29.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":828,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment to Mr. Michael Lee of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2964843,"source":{"system":"sec-edgar","filing":"0001104659-25-065256","document":"tm2519690-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465925065256/tm2519690-1_4seq1.xml","form_type":"4"}},{"id":1111428,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2025-06-13T22:00:54.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":12465234,"price":3.432,"value":42780683.088,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the June 11, 2025 exchange rate of approximately US$1.219 to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of June 11, 2025 was approximately $0.098."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 11, 2025, certain private investment vehicles managed by Redmile Group, LLC (collectively, the \"Redmile Clients\"), including RedCo II Master Fund, L.P. (\"RedCo II\"), entered into a securities purchase agreement (the \"Purchase Agreement\") in connection with a private placement by the Issuer to certain institutional investors. Pursuant to the terms of the Purchase Agreement, the Redmile Clients will acquire 15,734,267 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\") as of the closing date on June 16, 2025. The purchase price per Pre-Funded Warrant, excluding the exercise price (see footnote 2 below), is $3.432."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable by the holder at any time on or after the closing date of the private placement until the tenth anniversary of such closing date, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre-Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Redmile Group, LLC (\"Redmile\") may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"These reported securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed in the row above to disclose this fund's direct ownership."}],"balance_after":12465234,"derivative":{"exercise_date":"2025-06-16","underlying":"Common Share","underlying_shares":12465234},"source":{"system":"sec-edgar","filing":"0001104659-25-059489","document":"tm2517929-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925059489/tm2517929-1_4seq1.xml","form_type":"4"}},{"id":1111427,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2025-06-13T22:00:54.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":15734267,"price":3.432,"value":54000004.344,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the June 11, 2025 exchange rate of approximately US$1.219 to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of June 11, 2025 was approximately $0.098."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 11, 2025, certain private investment vehicles managed by Redmile Group, LLC (collectively, the \"Redmile Clients\"), including RedCo II Master Fund, L.P. (\"RedCo II\"), entered into a securities purchase agreement (the \"Purchase Agreement\") in connection with a private placement by the Issuer to certain institutional investors. Pursuant to the terms of the Purchase Agreement, the Redmile Clients will acquire 15,734,267 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\") as of the closing date on June 16, 2025. The purchase price per Pre-Funded Warrant, excluding the exercise price (see footnote 2 below), is $3.432."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable by the holder at any time on or after the closing date of the private placement until the tenth anniversary of such closing date, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre-Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These reported securities are directly owned by the Redmile Clients, including RedCo II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Redmile Group, LLC (\"Redmile\") may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any. This report shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15734267,"derivative":{"exercise_date":"2025-06-16","underlying":"Common Share","underlying_shares":15734267},"source":{"system":"sec-edgar","filing":"0001104659-25-059489","document":"tm2517929-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465925059489/tm2517929-1_4seq1.xml","form_type":"4"}},{"id":1129156,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T22:54:05.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in full and become exercisable upon the earlier of (i) May 29, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to Michael Lee's continued service on the board of directors of the Issuer through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The stock option award was granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the board of directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this equity award as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the equity award to Redmile. Mr. Lee disclaims beneficial ownership of the equity award, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The stock option award may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the equity award except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":55000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001104659-25-055045","document":"tm2516695-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465925055045/tm2516695-1_4seq1.xml","form_type":"4"}},{"id":1183349,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T21:00:16.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":828,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment to Mr. Michael Lee of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2964015,"source":{"system":"sec-edgar","filing":"0001104659-25-031353","document":"tm2511107-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465925031353/tm2511107-1_4seq1.xml","form_type":"4"}},{"id":1318596,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-01-02T21:00:33.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":1734,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment to Mr. Michael Lee of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Since the last Form 4 filing by the Reporting Persons, Redmile has ceased serving as the investment adviser to a sub-advised account that held 120,347 shares of the Issuer's common stock (such shares, the \"Account Shares\") and therefore no longer has voting or dispositive power with respect to such shares. Accordingly, the amount of shares beneficially owned by the Reporting Persons as disclosed herein does not include the Account Shares and each of the Reporting Persons disclaims beneficial ownership of the Account Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2963187,"source":{"system":"sec-edgar","filing":"0001104659-25-000432","document":"tm2432282-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465925000432/tm2432282-1_4seq1.xml","form_type":"4"}},{"id":1321588,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"other","planned":false,"acquired":false,"shares":56331,"price":1.68,"value":94636.08,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Represents the reference price associated with the cash-settled swap agreements."},{"field":"kind","element":"transactionCoding","label":"F6","text":"On the Effective Date, certain Redmile Funds closed out a portion of the swap agreements to which they were a party for cash in accordance with the terms of the swap agreements. See Footnote 8 below."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On the Effective Date, certain Redmile Funds closed out a portion of the swap agreements to which they were a party for cash in accordance with the terms of the swap agreements. See Footnote 8 below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Certain Redmile Funds are parties to swap agreements with counterparties. Each notional share subject to each swap agreement represents the economic equivalent of one share of Common Stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Redmile Funds that are parties to the swap agreements have the right to close out each swap at any time. Upon settlement of the swap agreements, either (i) the counterparty will pay to the Redmile Funds in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Funds will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":502769,"derivative":{"exercise_price":3.02,"underlying":"Common Stock","underlying_shares":56331},"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1321587,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Convertible Preferred Stock","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"other","planned":false,"acquired":true,"shares":116261,"price":8.4,"value":976592.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class A Preferred Stock is convertible into Common Stock in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The one-for-five conversion rate is taken into account in the amount of underlying Common Stock involved in the cross trade listed under Column 7 of Table II and used to determine the price of the Class A Preferred Stock in connection with the cross trade listed under Column 8 of Table II (which is equal to five times the price per share of the Common Stock underlying the Class A Preferred Stock at the time of the cross trade, which was $1.68 per share)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 20, 2024 (the \"Effective Date\"), certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\" and such private investment vehicles, the \"Redmile Funds\") engaged in cross trades with certain other Redmile Funds with respect to their shares of the Issuer's common stock, $0.001 par value per share (the \"Common Stock\") and shares of the Issuer's non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\"). The reported transactions occurred simultaneously when the price per share of the Common Stock was $1.68, and therefore the cross trades resulted in no profit to Redmile or Jeremy Green and resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class A Preferred Stock is convertible into Common Stock in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2755086,"derivative":{"underlying":"Common Stock","underlying_shares":581305},"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1321586,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Convertible Preferred Stock","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"other","planned":false,"acquired":false,"shares":116261,"price":8.4,"value":976592.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class A Preferred Stock is convertible into Common Stock in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The one-for-five conversion rate is taken into account in the amount of underlying Common Stock involved in the cross trade listed under Column 7 of Table II and used to determine the price of the Class A Preferred Stock in connection with the cross trade listed under Column 8 of Table II (which is equal to five times the price per share of the Common Stock underlying the Class A Preferred Stock at the time of the cross trade, which was $1.68 per share)."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 20, 2024 (the \"Effective Date\"), certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\" and such private investment vehicles, the \"Redmile Funds\") engaged in cross trades with certain other Redmile Funds with respect to their shares of the Issuer's common stock, $0.001 par value per share (the \"Common Stock\") and shares of the Issuer's non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\"). The reported transactions occurred simultaneously when the price per share of the Common Stock was $1.68, and therefore the cross trades resulted in no profit to Redmile or Jeremy Green and resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class A Preferred Stock is convertible into Common Stock in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2638825,"derivative":{"underlying":"Common Stock","underlying_shares":581305},"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1321585,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"purchase","planned":false,"acquired":true,"shares":397964,"price":1.68,"value":668579.52,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On the Effective Date, certain Redmile Funds purchased and sold shares of Common Stock concurrent with the cross trades at the same price. The reported cross trade, purchase and sales transactions occurred simultaneously when the price per share of the Common Shares was $1.68, and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":12884277,"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1321584,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"sale","planned":false,"acquired":false,"shares":341633,"price":1.68,"value":573943.44,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On the Effective Date, certain Redmile Funds purchased and sold shares of Common Stock concurrent with the cross trades at the same price. The reported cross trade, purchase and sales transactions occurred simultaneously when the price per share of the Common Shares was $1.68, and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":12486313,"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1321583,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"other","planned":false,"acquired":true,"shares":1084936,"price":1.68,"value":1822692.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 20, 2024 (the \"Effective Date\"), certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\" and such private investment vehicles, the \"Redmile Funds\") engaged in cross trades with certain other Redmile Funds with respect to their shares of the Issuer's common stock, $0.001 par value per share (the \"Common Stock\") and shares of the Issuer's non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\"). The reported transactions occurred simultaneously when the price per share of the Common Stock was $1.68, and therefore the cross trades resulted in no profit to Redmile or Jeremy Green and resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2024 (the \"Effective Date\"), certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\" and such private investment vehicles, the \"Redmile Funds\") engaged in cross trades with certain other Redmile Funds with respect to their shares of the Issuer's common stock, $0.001 par value per share (the \"Common Stock\") and shares of the Issuer's non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\"). The reported transactions occurred simultaneously when the price per share of the Common Stock was $1.68, and therefore the cross trades resulted in no profit to Redmile or Jeremy Green and resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":12827946,"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1321582,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-27T02:00:15.000Z","date":"2024-12-20","kind":"other","planned":false,"acquired":false,"shares":1084936,"price":1.68,"value":1822692.48,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 20, 2024 (the \"Effective Date\"), certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\" and such private investment vehicles, the \"Redmile Funds\") engaged in cross trades with certain other Redmile Funds with respect to their shares of the Issuer's common stock, $0.001 par value per share (the \"Common Stock\") and shares of the Issuer's non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\"). The reported transactions occurred simultaneously when the price per share of the Common Stock was $1.68, and therefore the cross trades resulted in no profit to Redmile or Jeremy Green and resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 20, 2024 (the \"Effective Date\"), certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\" and such private investment vehicles, the \"Redmile Funds\") engaged in cross trades with certain other Redmile Funds with respect to their shares of the Issuer's common stock, $0.001 par value per share (the \"Common Stock\") and shares of the Issuer's non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\"). The reported transactions occurred simultaneously when the price per share of the Common Stock was $1.68, and therefore the cross trades resulted in no profit to Redmile or Jeremy Green and resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"The securities reported herein are directly owned by the Redmile Funds. The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":11743010,"source":{"system":"sec-edgar","filing":"0001104659-24-131794","document":"tm2431906-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924131794/tm2431906-1_4seq1.xml","form_type":"4"}},{"id":1330729,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Convertible Preferred Stock","published_at":"2024-12-17T02:00:10.000Z","date":"2024-12-12","kind":"exercise","planned":false,"acquired":false,"shares":6022,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Class A Preferred Stock is convertible into the Issuer's common stock, $0.001 par value per share (the \"Common Stock\"), in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66, which is the equivalent of a one-for-five conversion rate."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 12, 2024, a private investment vehicle managed by Redmile Group, LLC (\"Redmile\") exercised its conversion right with respect to 6,022 non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\") held directly by such private investment vehicle."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class A Preferred Stock is convertible into the Issuer's common stock, $0.001 par value per share (the \"Common Stock\"), in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66, which is the equivalent of a one-for-five conversion rate."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Class A Preferred Stock is convertible into the Issuer's common stock, $0.001 par value per share (the \"Common Stock\"), in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66, which is the equivalent of a one-for-five conversion rate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are directly owned by private investment vehicles managed by Redmile. The reported securities may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":2755086,"derivative":{"underlying":"Common Stock","underlying_shares":30110},"source":{"system":"sec-edgar","filing":"0001104659-24-129070","document":"tm2431235-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924129070/tm2431235-1_4seq1.xml","form_type":"4"}},{"id":1330728,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T02:00:10.000Z","date":"2024-12-12","kind":"exercise","planned":false,"acquired":true,"shares":30110,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 12, 2024, a private investment vehicle managed by Redmile Group, LLC (\"Redmile\") exercised its conversion right with respect to 6,022 non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\") held directly by such private investment vehicle."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Class A Preferred Stock is convertible into the Issuer's common stock, $0.001 par value per share (the \"Common Stock\"), in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66, which is the equivalent of a one-for-five conversion rate."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 12, 2024, a private investment vehicle managed by Redmile Group, LLC (\"Redmile\") exercised its conversion right with respect to 6,022 non-voting Class A Convertible Preferred Stock of the Issuer (the \"Class A Preferred Stock\") held directly by such private investment vehicle."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Class A Preferred Stock is convertible into the Issuer's common stock, $0.001 par value per share (the \"Common Stock\"), in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the \"Certificate of Designation\") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66, which is the equivalent of a one-for-five conversion rate."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Since the last Form 4 filing by Redmile and Mr. Green, Redmile has ceased serving as the investment adviser to a sub-advised account that held 382,552 shares of the Issuer's Common Shares (such shares, the \"Account Shares\") and therefore no longer has voting or dispositive power with respect to such shares. Accordingly, the amount of shares beneficially owned by Redmile and Mr. Green as disclosed herein does not include the Account Shares and each of Redmile and Mr. Green disclaims beneficial ownership of the Account Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are directly owned by private investment vehicles managed by Redmile. The reported securities may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles and by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":12827946,"source":{"system":"sec-edgar","filing":"0001104659-24-129070","document":"tm2431235-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924129070/tm2431235-1_4seq1.xml","form_type":"4"}},{"id":1332215,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-14T02:00:14.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.81,"value":190500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.64 to $3.9, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed in the row above to disclose this fund's direct ownership."}],"balance_after":13145712,"source":{"system":"sec-edgar","filing":"0001104659-24-128575","document":"tm2431001-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924128575/tm2431001-1_4seq1.xml","form_type":"4"}},{"id":1332214,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-14T02:00:14.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":2.28,"value":114000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.165 to $2.4, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed in the row above to disclose this fund's direct ownership."}],"balance_after":13095712,"source":{"system":"sec-edgar","filing":"0001104659-24-128575","document":"tm2431001-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924128575/tm2431001-1_4seq1.xml","form_type":"4"}},{"id":1332213,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-14T02:00:14.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.81,"value":190500.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.64 to $3.9, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (collectively, the \"Redmile Clients\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15666731,"source":{"system":"sec-edgar","filing":"0001104659-24-128575","document":"tm2431001-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924128575/tm2431001-1_4seq1.xml","form_type":"4"}},{"id":1332212,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-14T02:00:14.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":2.28,"value":114000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.165 to $2.4, inclusive. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (collectively, the \"Redmile Clients\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15616731,"source":{"system":"sec-edgar","filing":"0001104659-24-128575","document":"tm2431001-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924128575/tm2431001-1_4seq1.xml","form_type":"4"}},{"id":1340325,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":true,"shares":26656,"price":2.07,"value":55177.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the December 4, 2024 exchange rate of $1.13 USD to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of December 4, 2024 is approximately $0.09."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Pre-Funded Warrants are exercisable by the holder at any time after their original issuance until the tenth anniversary of their original issuance, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed in the row immediately above to disclose this fund's direct ownership."}],"balance_after":6133837,"derivative":{"exercise_date":"2024-05-08","underlying":"Common Shares","underlying_shares":26656},"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340324,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":true,"shares":26656,"price":2.07,"value":55177.92,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the December 4, 2024 exchange rate of $1.13 USD to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of December 4, 2024 is approximately $0.09."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Pre-Funded Warrants are exercisable by the holder at any time after their original issuance until the tenth anniversary of their original issuance, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":8163265,"derivative":{"exercise_date":"2024-05-08","underlying":"Common Shares","underlying_shares":26656},"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340323,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":26656,"price":2.07,"value":55177.92,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the December 4, 2024 exchange rate of $1.13 USD to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of December 4, 2024 is approximately $0.09."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Pre-Funded Warrants are exercisable by the holder at any time after their original issuance until the tenth anniversary of their original issuance, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre Funded Warrant with the Issuer for a new Pre-Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":8136609,"derivative":{"exercise_date":"2024-05-08","underlying":"Common Shares","underlying_shares":26656},"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340322,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":true,"shares":50672,"price":2.07,"value":104891.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"These securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed in the row immediately above to disclose this fund's direct ownership."}],"balance_after":13045712,"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340321,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":true,"shares":50672,"price":2.07,"value":104891.04,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15566731,"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340320,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":50672,"price":2.07,"value":104891.04,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15516059,"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340319,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-12-07T02:00:37.000Z","date":"2024-12-04","kind":"sale","planned":false,"acquired":false,"shares":25352,"price":2.07,"value":52478.64,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), engaged in cross trades with respect to 50,672 Common Shares and 26,656 pre-funded warrants to purchase Common Shares (the \"Pre-Funded Warrants\"). A Redmile Client also sold an additional 25,352 Common Shares concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $2.07 (or $1.98 for the Pre-Funded Warrants, which excludes the exercise price, see footnote 6 below), and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades resulted in no change in either of their aggregate beneficial ownership."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the last Form 4 filing by Redmile and Mr. Green, Redmile has ceased serving as the investment adviser to a sub-advised account that held 77,134 shares of the Issuer's Common Shares (such shares, the \"Account Shares\") and therefore no longer has voting or dispositive power with respect to such shares. Accordingly, the amount of shares beneficially owned by Redmile and Mr. Green as disclosed herein does not include the Account Shares and each of Redmile and Mr. Green disclaims beneficial ownership of the Account Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These reported securities are directly owned by the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15566731,"source":{"system":"sec-edgar","filing":"0001104659-24-126422","document":"tm2430300-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126422/tm2430300-1_4seq1.xml","form_type":"4"}},{"id":1340318,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-12-07T02:00:15.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":true,"shares":1026888,"price":1.25,"value":1283610.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles (the \"Redmile Clients\") managed by Redmile Group, LLC (\"Redmile\") engaged in cross trades with respect to 1,026,888 shares of Common Stock. Certain other Redmile Clients purchased and sold shares of Common Stock concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $1.25, and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades and other transactions resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":5539724,"source":{"system":"sec-edgar","filing":"0001104659-24-126421","document":"tm2430300-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126421/tm2430300-2_4seq1.xml","form_type":"4"}},{"id":1340317,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-12-07T02:00:15.000Z","date":"2024-12-04","kind":"other","planned":false,"acquired":false,"shares":1026888,"price":1.25,"value":1283610.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles (the \"Redmile Clients\") managed by Redmile Group, LLC (\"Redmile\") engaged in cross trades with respect to 1,026,888 shares of Common Stock. Certain other Redmile Clients purchased and sold shares of Common Stock concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $1.25, and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades and other transactions resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":4512836,"source":{"system":"sec-edgar","filing":"0001104659-24-126421","document":"tm2430300-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126421/tm2430300-2_4seq1.xml","form_type":"4"}},{"id":1340316,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-12-07T02:00:15.000Z","date":"2024-12-04","kind":"purchase","planned":false,"acquired":true,"shares":133371,"price":1.25,"value":166713.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles (the \"Redmile Clients\") managed by Redmile Group, LLC (\"Redmile\") engaged in cross trades with respect to 1,026,888 shares of Common Stock. Certain other Redmile Clients purchased and sold shares of Common Stock concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $1.25, and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades and other transactions resulted in no change in either of their aggregate beneficial ownership."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":5539724,"source":{"system":"sec-edgar","filing":"0001104659-24-126421","document":"tm2430300-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126421/tm2430300-2_4seq1.xml","form_type":"4"}},{"id":1340315,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-12-07T02:00:15.000Z","date":"2024-12-04","kind":"sale","planned":false,"acquired":false,"shares":133371,"price":1.25,"value":166713.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 4, 2024, certain private investment vehicles (the \"Redmile Clients\") managed by Redmile Group, LLC (\"Redmile\") engaged in cross trades with respect to 1,026,888 shares of Common Stock. Certain other Redmile Clients purchased and sold shares of Common Stock concurrently with the cross trades at the same price. The reported transactions occurred simultaneously, at which time the price per share of the Common Shares was $1.25, and therefore the reported transactions resulted in no profit to Redmile or Jeremy Green and the cross trades and other transactions resulted in no change in either of their aggregate beneficial ownership."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Since the last Form 4 filing by Redmile and Mr. Green, Redmile has ceased serving as the investment adviser to a sub-advised account that held 75,765 shares of the Issuer's Common Shares (such shares, the \"Account Shares\") and therefore no longer has voting or dispositive power with respect to such shares. Accordingly, the amount of shares beneficially owned by Redmile and Mr. Green as disclosed herein does not include the Account Shares and each of Redmile and Mr. Green disclaims beneficial ownership of the Account Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Redmile may be deemed to beneficially own the reported securities as the investment manager of the Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":5406353,"source":{"system":"sec-edgar","filing":"0001104659-24-126421","document":"tm2430300-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924126421/tm2430300-2_4seq1.xml","form_type":"4"}},{"id":1390716,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Breakeven Warrants","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1093799,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Breakeven Warrants became exercisable upon the closing of the closing of the underwritten public offering on November 20, 2023. The Breakeven Warrants will expire on the seventh anniversary of the issuance date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Breakeven Warrants became exercisable upon the closing of the closing of the underwritten public offering on November 20, 2023. The Breakeven Warrants will expire on the seventh anniversary of the issuance date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The shares of Common Stock, Pre-Funded Warrants and Breakeven Warrants of the Issuer reported herein are owned directly by RedCo II Master Fund, L.P."}],"balance_after":0,"derivative":{"exercise_price":1.75,"underlying":"Common Stock","underlying_shares":1093799},"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1390715,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Breakeven Warrants","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1093799,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Breakeven Warrants became exercisable upon the closing of the closing of the underwritten public offering on November 20, 2023. The Breakeven Warrants will expire on the seventh anniversary of the issuance date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Breakeven Warrants became exercisable upon the closing of the closing of the underwritten public offering on November 20, 2023. The Breakeven Warrants will expire on the seventh anniversary of the issuance date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities of the Issuer reported herein are directly owned by certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), including RedCo II Master Fund, L.P. and Redmile Private Investments II, L.P. (the \"Reporting Funds\"), and may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of the Reporting Funds, Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":1.75,"underlying":"Common Stock","underlying_shares":1093799},"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1390714,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3125195,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Pre-Funded Warrants are exercisable by the holder at any time until fully exercised at an exercise price of $0.0001 per share of the Issuer's common stock (the \"Pre-Funded Warrant Share\"), subject to a limitation on the right of the Issuer to issue the Pre-Funded Warrant Shares if and to the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Pre-Funded Warrants are exercisable by the holder at any time until fully exercised at an exercise price of $0.0001 per share of the Issuer's common stock (the \"Pre-Funded Warrant Share\"), subject to a limitation on the right of the Issuer to issue the Pre-Funded Warrant Shares if and to the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The shares of Common Stock, Pre-Funded Warrants and Breakeven Warrants of the Issuer reported herein are owned directly by RedCo II Master Fund, L.P."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":3125195},"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1390713,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3125195,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Pre-Funded Warrants are exercisable by the holder at any time until fully exercised at an exercise price of $0.0001 per share of the Issuer's common stock (the \"Pre-Funded Warrant Share\"), subject to a limitation on the right of the Issuer to issue the Pre-Funded Warrant Shares if and to the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Pre-Funded Warrants are exercisable by the holder at any time until fully exercised at an exercise price of $0.0001 per share of the Issuer's common stock (the \"Pre-Funded Warrant Share\"), subject to a limitation on the right of the Issuer to issue the Pre-Funded Warrant Shares if and to the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities of the Issuer reported herein are directly owned by certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), including RedCo II Master Fund, L.P. and Redmile Private Investments II, L.P. (the \"Reporting Funds\"), and may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of the Reporting Funds, Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":3125195},"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1390712,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6218238,"price":2.35,"value":14612859.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The shares of Common Stock  of the Issuer reported herein are owned directly by Redmile Private Investments II, L.P."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1390711,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9446146,"price":2.35,"value":22198443.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The shares of Common Stock, Pre-Funded Warrants and Breakeven Warrants of the Issuer reported herein are owned directly by RedCo II Master Fund, L.P."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1390710,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":87005,"kind":"person","name":"Redmile Private Investments II, L.P.","position":4,"cik":"0001629493","reported_name":"Redmile Private Investments II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-04T21:01:03.000Z","date":"2024-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16421788,"price":2.35,"value":38591201.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 2, 2024, the Issuer completed its previously announced merger transaction with Commure, Inc. (\"Parent\") and Anderson Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"). Under the terms of the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\"). On the effective date and time of the Merger, all of the outstanding shares of the Issuer's Common Stock, the outstanding restricted stock units that were vested at the effective time of the Merger, the outstanding and unexercised warrants to purchase shares of the Issuer's Common Stock that provided for their deemed exercise as a result of the Merger, and the outstanding and unexercised options to purchase the Issuer's Common Stock or stock appreciation rights that were vested at the effective time of the Merger,"},{"field":"shares","element":"transactionShares","label":"F2","text":"(cont'd) in each case immediately prior to the effective time of the Merger, including the Common Stock and warrants owned by the Redmile Funds (as defined below) and the Common Stock owned by Redmile Group, LLC (\"Redmile\"), were cancelled and converted into the right to receive cash based on a purchase price of $2.35 per share in accordance with the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities of the Issuer reported herein are directly owned by certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), including RedCo II Master Fund, L.P. and Redmile Private Investments II, L.P. (the \"Reporting Funds\"), and may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of the Reporting Funds, Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such Reporting Person is a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-106315","document":"tm2425580-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924106315/tm2425580-3_4seq1.xml","form_type":"4"}},{"id":1394401,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T20:16:24.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1734,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are fully vested restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment to Mr. Michael Lee of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3081800,"source":{"system":"sec-edgar","filing":"0001104659-24-105559","document":"tm2425347-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924105559/tm2425347-2_4seq1.xml","form_type":"4"}},{"id":1459742,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-07-04T00:00:13.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":2.81,"value":1124000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are directly owned by RedCo II and this transaction is a repetition of the same transaction disclosed above in the first row to disclose this fund's direct ownership."}],"balance_after":12995040,"source":{"system":"sec-edgar","filing":"0001104659-24-077865","document":"tm2418671-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924077865/tm2418671-3_4seq1.xml","form_type":"4"}},{"id":1459741,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value CHF 0.08 per share","published_at":"2024-07-04T00:00:13.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":2.81,"value":1124000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles and sub-advised accounts managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles and sub-advised accounts managed by Redmile, the \"Redmile Clients\"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15669217,"source":{"system":"sec-edgar","filing":"0001104659-24-077865","document":"tm2418671-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924077865/tm2418671-3_4seq1.xml","form_type":"4"}},{"id":1462940,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T21:30:51.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1734,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment to Mr. Michael Lee of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3080066,"source":{"system":"sec-edgar","filing":"0001104659-24-077493","document":"tm2418671-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924077493/tm2418671-2_4seq1.xml","form_type":"4"}},{"id":1471936,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T23:22:59.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,700 shares of the Issuer's common stock, which will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) immediately prior to the next annual meeting of the Issuer's shareholders, subject to Mr. Michael Lee's continued service to the Issuer through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":27700,"derivative":{"exercise_price":4.37,"expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0001104659-24-074032","document":"tm2417794-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924074032/tm2417794-1_4seq1.xml","form_type":"4"}},{"id":1475077,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T01:30:10.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":12879,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2024 (the \"Grant Date\"), at the election of Mr. Robert Faulkner, the reported shares of the Common Stock were issued in lieu of cash compensation that Mr. Faulkner is entitled to receive for his services as a member of the Issuer's Board of Directors for Q2 2024 based on the closing price of the Common Stock on the Grant Date. The reported shares are fully vested and unrestricted, subject to the terms and conditions set forth in the Issuer's 2020 Equity Incentive Plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Faulkner, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile and its affiliates, Mr. Faulkner holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Other than the reported securities, the common stock of the Issuer reported herein are directly owned by the certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":16421788,"source":{"system":"sec-edgar","filing":"0001104659-24-073005","document":"tm2417533-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924073005/tm2417533-1_4seq1.xml","form_type":"4"}},{"id":1478996,"issuer":{"id":4685,"kind":"organization","name":"Absci Corp","symbol":"ABSI"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T23:47:08.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":36274,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 12, 2024, Mr. Nagpal received a grant of options to purchase 36,274 shares of the Issuer's Common Stock. Pursuant to the Issuer's amended Non-Employee Director Compensation Policy, the option award will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Issuer's next annual meeting of stockholders, subject to Mr. Nagpal's continuous service to the Issuer through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The restricted stock units and stock option (the \"reported securities\") were granted to Mr. Nagpal, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Nagpal holds the reported securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the reported securities to Redmile. Mr. Nagpal disclaims beneficial ownership of the reported securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Nagpal is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":36274,"derivative":{"exercise_price":4.96,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":36274},"source":{"system":"sec-edgar","filing":"0001104659-24-071871","document":"tm2417342-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672688/000110465924071871/tm2417342-1_4seq1.xml","form_type":"4"}},{"id":1478995,"issuer":{"id":4685,"kind":"organization","name":"Absci Corp","symbol":"ABSI"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T23:47:08.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8820,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 12, 2024, Mr. Amrit Nagpal received 8,820 restricted stock units (\"RSUs\") issued under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock, $0.0001 par value (the \"Common Stock\"). The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to Mr. Nagpal's continuous service to the Issuer through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The restricted stock units and stock option (the \"reported securities\") were granted to Mr. Nagpal, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Nagpal holds the reported securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the reported securities to Redmile. Mr. Nagpal disclaims beneficial ownership of the reported securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Nagpal is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":8262136,"source":{"system":"sec-edgar","filing":"0001104659-24-071871","document":"tm2417342-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672688/000110465924071871/tm2417342-1_4seq1.xml","form_type":"4"}},{"id":1483335,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T22:19:21.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in full and become exercisable upon the earlier of (i) June 7, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to Michael Lee's continued service on the board of directors of the Issuer through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The stock option award was granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the board of directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this equity award as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the equity award to Redmile. Mr. Lee disclaims beneficial ownership of the equity award, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The stock option award may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the equity award except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":40000,"derivative":{"exercise_price":3.68,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-24-070506","document":"tm2416874-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924070506/tm2416874-1_4seq1.xml","form_type":"4"}},{"id":1520547,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2024-05-10T20:01:19.000Z","date":"2024-05-08","kind":"purchase","planned":false,"acquired":true,"shares":8163265,"price":4.812,"value":39281631.18,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 8, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), acquired, in an underwritten public offering, pre-funded warrants (the \"Pre-Funded Warrants\") to purchase Common Shares of the Issuer (the \"Pre-Funded Warrant Shares\") at a purchase price per Pre-Funded Warrant equal to $4.812."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the May 8, 2024 exchange rate of $1.1013 USD to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of May 8, 2024 is approximately $0.088."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable by the holder at any time after their original issuance until the tenth anniversary of their original issuance, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre Funded Warrant with the Issuer for a new Pre Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The securities reported herein are directly owned by the Redmile Clients, including RedCo II."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Clients and by Jeremy Green as the managing principal of Redmile. Each of Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":8163265,"derivative":{"exercise_date":"2024-05-08","underlying":"Common Shares","underlying_shares":8163265},"source":{"system":"sec-edgar","filing":"0001104659-24-059881","document":"tm2414067-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924059881/tm2414067-1_4seq1.xml","form_type":"4"}},{"id":1520546,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2024-05-10T20:01:19.000Z","date":"2024-05-08","kind":"purchase","planned":false,"acquired":true,"shares":6107181,"price":4.812,"value":29387754.972,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 8, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles managed by Redmile, the \"Redmile Clients\"), acquired, in an underwritten public offering, pre-funded warrants (the \"Pre-Funded Warrants\") to purchase Common Shares of the Issuer (the \"Pre-Funded Warrant Shares\") at a purchase price per Pre-Funded Warrant equal to $4.812."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the Pre-Funded Warrants is CHF 0.08 per Pre-Funded Warrant Share. Based on the May 8, 2024 exchange rate of $1.1013 USD to CHF 1.00, the exercise price of the Pre-Funded Warrants in US Dollars as of May 8, 2024 is approximately $0.088."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Pre-Funded Warrants are exercisable by the holder at any time after their original issuance until the tenth anniversary of their original issuance, subject to a 9.99% beneficial ownership blocker. At any time during the last 90 days of the term of the Pre-Funded Warrants, the holder thereof may exchange a Pre Funded Warrant with the Issuer for a new Pre Funded Warrant to purchase the number of Pre-Funded Warrant Shares then remaining under such Pre-Funded Warrant, with a subsequent ten-year exercise period."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities are directly owned by RedCo II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"The reported securities may be deemed beneficially owned by Redmile as investment manager of the Redmile Clients and by Jeremy Green as the managing principal of Redmile. Each of Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":6107181,"derivative":{"exercise_date":"2024-05-08","underlying":"Common Shares","underlying_shares":6107181},"source":{"system":"sec-edgar","filing":"0001104659-24-059881","document":"tm2414067-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924059881/tm2414067-1_4seq1.xml","form_type":"4"}},{"id":1556156,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T01:32:00.000Z","date":"2024-03-28","kind":"other","planned":false,"acquired":false,"shares":4425,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 28, 2024, one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\") made a pro rata in kind distribution of the Issuer's common stock, $0.0001 par value per share (the \"Common Stock\"), directly held by that private investment vehicle for no consideration. As a result, Redmile no longer has voting or dispositive power with respect to the 4,425 shares of the Issuer's Common Stock held by such private investment vehicle."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by certain private investment vehicles managed by Redmile (the \"Redmile Funds\"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":5615489,"source":{"system":"sec-edgar","filing":"0001104659-24-042087","document":"tm2410246-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924042087/tm2410246-3_4seq1.xml","form_type":"4"}},{"id":1556241,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T21:30:12.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":1734,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment to Mr. Michael Lee of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities were granted to Mr. Lee, a managing director of Redmile, in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Lee disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3078332,"source":{"system":"sec-edgar","filing":"0001104659-24-042085","document":"tm2410246-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924042085/tm2410246-1_4seq1.xml","form_type":"4"}},{"id":1556240,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T21:30:12.000Z","date":"2024-03-28","kind":"other","planned":false,"acquired":false,"shares":12464,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 28, 2024, one of the private investment vehicles managed by Redmile Group, LLC (\"Redmile\") made a pro rata in kind distribution of the Issuer's common stock, $0.01 par value per share (the \"Common Stock\"), directly held by that private investment vehicle for no consideration. As a result, Redmile no longer has voting or dispositive power with respect to the 12,464 shares of the Issuer's Common Stock held by such private investment vehicle."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are directly held by certain private investment vehicles managed by Redmile (the \"Redmile Funds\"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the \"Reporting Persons\"). The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3076598,"source":{"system":"sec-edgar","filing":"0001104659-24-042085","document":"tm2410246-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924042085/tm2410246-1_4seq1.xml","form_type":"4"}},{"id":1561811,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrants to Purchase Common Stock","published_at":"2024-03-26T01:30:19.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":3636364,"price":5.499,"value":19996365.636,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 21, 2024, concurrently with the underwritten public offering of the Issuer's common stock, par value $0.001 per share (the \"Common Stock\"), a private investment vehicle managed by Redmile Group, LLC (\"Redmile\") acquired pre-funded warrants (the \"Pre-Funded Warrants\") to purchase shares of Common Stock (the \"Pre-Funded Warrant Shares\") for a purchase price per Pre-Funded Warrant equal to $5.50, less $0.001, in a private placement by the Issuer to certain investors pursuant to the terms of a securities purchase agreement, dated as of March 19, 2024 (the \"Purchase Agreement\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants are exercisable by the holder at any time on or after the closing date of the Purchase Agreement until fully exercised at an exercise price of $0.001 per Pre-Funded Warrant Share, subject to a 9.99% beneficial ownership blocker and a limitation on the right of the Issuer to issue the Pre-Funded Warrant Shares if and the extent that such exercise would violate the rules or regulations of Nasdaq Stock Market LLC. The Pre-Funded Warrants have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities reported herein are directly owned by the certain private investment vehicles managed by Redmile, none of which individually is a 10% owner. The reported securities may be deemed beneficially owned by Redmile as investment manager of the private investment vehicles and by Jeremy Green as the managing principal of Redmile. Each of Redmile and Mr. Green (the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that the Reporting Persons are a beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3893674,"derivative":{"exercise_price":0.001,"exercise_date":"2024-03-21","underlying":"Common Stock","underlying_shares":3636364},"source":{"system":"sec-edgar","filing":"0001104659-24-038585","document":"tm249642-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000110465924038585/tm249642-1_4seq1.xml","form_type":"4"}},{"id":1568313,"issuer":{"id":86996,"kind":"organization","name":"Augmedix, Inc.","symbol":"AUGX"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-20T01:30:24.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2024 (the \"Grant Date\"), at the election of Mr. Robert Faulkner, the reported shares of the Common Stock were issued in lieu of cash compensation that Mr. Faulkner is entitled to receive for his services as a member of the Issuer's Board of Directors for Q1 2024 based on the closing price of the Common Stock on the Grant Date. The reported shares are fully vested and unrestricted, subject to the terms and conditions set forth in the Issuer's 2020 Equity Incentive Plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities were granted to Mr. Faulkner, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile and its affiliates, Mr. Faulkner holds these securities as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner disclaims beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Other than the reported securities, the common stock of the Issuer reported herein are directly owned by the certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may be deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaims beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that such Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":16408909,"source":{"system":"sec-edgar","filing":"0001104659-24-036336","document":"tm249187-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924036336/tm249187-1_4seq1.xml","form_type":"4"}},{"id":1576667,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-14T19:45:31.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest each month that is completed after the date of the Issuer's first annual stockholder meeting following the grant date of the options (the \"Annual Meeting\"), provided that the options will vest in full on the earlier of (i) the 12-month anniversary of the Annual Meeting, or (ii) the date of the Issuer's next annual stockholder meeting, in each case subject to Mike Lee continuing to provide his service as a member of the Board of Directors of the Issuer through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the stock option for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the stock option for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":29400,"derivative":{"exercise_price":9.95,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":29400},"source":{"system":"sec-edgar","filing":"0001104659-24-034643","document":"tm248883-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924034643/tm248883-2_4seq1.xml","form_type":"4"}},{"id":1578920,"issuer":{"id":15235,"kind":"organization","name":"Science 37 Holdings, Inc.","symbol":"SNCE"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner and Director"}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner and Director"}}],"security":"Earn-Out Right","published_at":"2024-03-13T17:17:59.000Z","date":"2024-03-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":95765,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, all \"Earn-Out Rights\" (that is, all rights to receive the Issuer's Common Stock that were reserved for issuance as \"Earn-Out Shares\" pursuant to, and under the circumstances set forth in, Section 2.8 of the Agreement and Plan of Merger dated as of May 6, 2021 by and among the Issuer, LifeSci Acquisition II Corp. and LifeSci Acquisition II Merger Sub, Inc.) that were outstanding immediately prior to the Effective Time automatically were cancelled and ceased to exist at the Effective Time."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company (\"Parent\"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for all outstanding shares of the Issuer's common stock (\"Common Stock\") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the \"Offer Price\"), which such tender offer expired on March 11, 2024. On March 12, 2024, after completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the \"Effective Time\"). These shares of Common Stock were tendered for purchase pursuant to the tender offer."},{"field":"shares","element":"transactionShares","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, all \"Earn-Out Rights\" (that is, all rights to receive the Issuer's Common Stock that were reserved for issuance as \"Earn-Out Shares\" pursuant to, and under the circumstances set forth in, Section 2.8 of the Agreement and Plan of Merger dated as of May 6, 2021 by and among the Issuer, LifeSci Acquisition II Corp. and LifeSci Acquisition II Merger Sub, Inc.) that were outstanding immediately prior to the Effective Time automatically were cancelled and ceased to exist at the Effective Time."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company (\"Parent\"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for all outstanding shares of the Issuer's common stock (\"Common Stock\") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the \"Offer Price\"), which such tender offer expired on March 11, 2024. On March 12, 2024, after completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the \"Effective Time\"). These shares of Common Stock were tendered for purchase pursuant to the tender offer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, all \"Earn-Out Rights\" (that is, all rights to receive the Issuer's Common Stock that were reserved for issuance as \"Earn-Out Shares\" pursuant to, and under the circumstances set forth in, Section 2.8 of the Agreement and Plan of Merger dated as of May 6, 2021 by and among the Issuer, LifeSci Acquisition II Corp. and LifeSci Acquisition II Merger Sub, Inc.) that were outstanding immediately prior to the Effective Time automatically were cancelled and ceased to exist at the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, all \"Earn-Out Rights\" (that is, all rights to receive the Issuer's Common Stock that were reserved for issuance as \"Earn-Out Shares\" pursuant to, and under the circumstances set forth in, Section 2.8 of the Agreement and Plan of Merger dated as of May 6, 2021 by and among the Issuer, LifeSci Acquisition II Corp. and LifeSci Acquisition II Merger Sub, Inc.) that were outstanding immediately prior to the Effective Time automatically were cancelled and ceased to exist at the Effective Time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Other than the reported securities that were granted to Mr. Faulkner, the common stock of the Issuer reported herein was directly owned by the certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may have been deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also have been deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaimed beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that either of the Reporting Persons was a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95765},"source":{"system":"sec-edgar","filing":"0001104659-24-034011","document":"tm248657-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819113/000110465924034011/tm248657-2_4seq1.xml","form_type":"4"}},{"id":1578919,"issuer":{"id":15235,"kind":"organization","name":"Science 37 Holdings, Inc.","symbol":"SNCE"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner and Director"}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner and Director"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-03-13T17:17:59.000Z","date":"2024-03-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2068,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company (\"Parent\"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for all outstanding shares of the Issuer's common stock (\"Common Stock\") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the \"Offer Price\"), which such tender offer expired on March 11, 2024. On March 12, 2024, after completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the \"Effective Time\"). These shares of Common Stock were tendered for purchase pursuant to the tender offer."},{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company (\"Parent\"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for all outstanding shares of the Issuer's common stock (\"Common Stock\") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the \"Offer Price\"), which such tender offer expired on March 11, 2024. On March 12, 2024, after completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the \"Effective Time\"). These shares of Common Stock were tendered for purchase pursuant to the tender offer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock that was outstanding and unexercised immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Certain of these securities were granted to Mr. Faulkner, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile and its affiliates, Mr. Faulkner held these securities as a nominee on behalf, and for the sole benefit, of Redmile and assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner has disclaimed beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner was the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Other than the reported securities that were granted to Mr. Faulkner, the common stock of the Issuer reported herein was directly owned by the certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may have been deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also have been deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaimed beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that either of the Reporting Persons was a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":201,"underlying":"Common Stock","underlying_shares":2068},"source":{"system":"sec-edgar","filing":"0001104659-24-034011","document":"tm248657-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819113/000110465924034011/tm248657-2_4seq1.xml","form_type":"4"}},{"id":1578918,"issuer":{"id":15235,"kind":"organization","name":"Science 37 Holdings, Inc.","symbol":"SNCE"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner and Director"}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner and Director"}}],"security":"Common Stock","published_at":"2024-03-13T17:17:59.000Z","date":"2024-03-12","kind":"other","planned":false,"acquired":false,"shares":1017203,"price":5.75,"value":5848917.25,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of January 28, 2024, among the Issuer, eMed, LLC, a Delaware limited liability company (\"Parent\"), and Marlin Merger Sub Corporation, a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for all outstanding shares of the Issuer's common stock (\"Common Stock\") at a purchase price of $5.75 per share, without interest and subject to applicable withholding taxes (the \"Offer Price\"), which such tender offer expired on March 11, 2024. On March 12, 2024, after completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of March 12, 2024 (such date and time of such merger, the \"Effective Time\"). These shares of Common Stock were tendered for purchase pursuant to the tender offer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Common Stock subject to such restricted stock unit. This number includes 24,742 unvested restricted stock units."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Certain of these securities were granted to Mr. Faulkner, a managing director of Redmile Group, LLC (\"Redmile\"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile and its affiliates, Mr. Faulkner held these securities as a nominee on behalf, and for the sole benefit, of Redmile and assigned all economic, pecuniary and voting rights in respect of the securities to Redmile. Mr. Faulkner has disclaimed beneficial ownership of the securities, and the filing of this Form 4 shall not be deemed an admission that Mr. Faulkner was the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Other than the reported securities that were granted to Mr. Faulkner, the common stock of the Issuer reported herein was directly owned by the certain private investment vehicles managed by Redmile (each, a \"Redmile Fund\"), and may have been deemed beneficially owned by Redmile as investment manager of the Redmile Funds. The reported securities may also have been deemed beneficially owned by Jeremy Green as the principal of Redmile. Each of Redmile and Mr. Green (collectively, the \"Reporting Persons\") disclaimed beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that either of the Reporting Persons was a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-034011","document":"tm248657-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819113/000110465924034011/tm248657-2_4seq1.xml","form_type":"4"}},{"id":1596324,"issuer":{"id":4685,"kind":"organization","name":"Absci Corp","symbol":"ABSI"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T02:30:43.000Z","date":"2024-03-01","kind":"purchase","planned":false,"acquired":true,"shares":222222,"price":4.5,"value":999999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 1, 2024, certain private investment vehicles managed by Redmile Group, LLC (\"Redmile\"), purchased 222,222 shares of the Issuer's Common Stock in an underwritten offering by the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities of the Issuer reported herein are directly owned by certain private investment vehicles managed by Redmile, and may be deemed beneficially owned by Redmile as investment manager of such private investment vehicles. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the stock option for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":8253316,"source":{"system":"sec-edgar","filing":"0001104659-24-031215","document":"tm247653-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672688/000110465924031215/tm247653-2_4seq1.xml","form_type":"4"}},{"id":1606963,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Voting Common Stock","published_at":"2024-03-01T21:30:17.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":113400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 28, 2024, a private investment vehicle managed by Redmile Group, LLC (\"Redmile\") converted certain shares of the Issuer's non-voting common stock (\"Non-Voting Stock\") to shares of the Issuer's common stock (\"Voting Stock\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of Non-Voting Stock are convertible into shares of Voting Stock in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation (the \"Certificate\") at any time and from time to time at the holder's election on a 1-for-1 basis for no additional consideration. Such conversion rate is reflected in the amount listed under Column 7. The Certificate provides that the holder may not convert any shares of Non-Voting Stock if, after giving effect to the attempted conversion, the holder and its affiliates would collectively beneficially own more than 4.99% of the number of shares of Voting Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 4, 2023, the private investment vehicles managed by Redmile (the \"Redmile Clients\") that directly own shares of the Non-Voting Stock elected to increase the beneficial ownership percentage applicable to their shares from 4.99% to 10.95%, which increase became effective 61 days after the date of such election. The Non-Voting Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by the Redmile Clients and may be deemed beneficially owned by Redmile as the investment manager of such Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":7199325,"derivative":{"exercise_date":"2024-02-28","underlying":"Common Stock","underlying_shares":113400},"source":{"system":"sec-edgar","filing":"0001104659-24-030166","document":"tm247650-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924030166/tm247650-1_4seq1.xml","form_type":"4"}},{"id":1606962,"issuer":{"id":76422,"kind":"organization","name":"IGM Biosciences, Inc.","symbol":"IGMS"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-03-01T21:30:17.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":113400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 28, 2024, a private investment vehicle managed by Redmile Group, LLC (\"Redmile\") converted certain shares of the Issuer's non-voting common stock (\"Non-Voting Stock\") to shares of the Issuer's common stock (\"Voting Stock\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reported securities are held directly by the Redmile Clients and may be deemed beneficially owned by Redmile as the investment manager of such Redmile Clients. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":3089062,"source":{"system":"sec-edgar","filing":"0001104659-24-030166","document":"tm247650-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1496323/000110465924030166/tm247650-1_4seq1.xml","form_type":"4"}},{"id":1651482,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-02-10T02:50:25.000Z","date":"2024-02-07","kind":"purchase","planned":false,"acquired":true,"shares":107590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents the reference price associated with the swap agreements."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Certain Redmile Clients, including RedCo II, are parties to swap agreements with counterparties that provide those Redmile Clients with economic exposure to notional shares of the Issuer. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(cont'd) Accordingly, the Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Reporting Persons have the right to terminate and close out each swap at any time."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are directly owned by RedCo II."}],"balance_after":107590,"derivative":{"exercise_price":3.9913,"underlying":"Common Shares","underlying_shares":107590},"source":{"system":"sec-edgar","filing":"0001104659-24-013529","document":"tm245827-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924013529/tm245827-2_4seq1.xml","form_type":"4"}},{"id":1651481,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-02-10T02:50:25.000Z","date":"2024-02-02","kind":"purchase","planned":false,"acquired":true,"shares":11159,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents the reference price associated with the swap agreements."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Certain Redmile Clients, including RedCo II, are parties to swap agreements with counterparties that provide those Redmile Clients with economic exposure to notional shares of the Issuer. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(cont'd) Accordingly, the Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Reporting Persons have the right to terminate and close out each swap at any time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles and sub-advised accounts managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles and sub-advised accounts managed by Redmile, the \"Redmile Clients\"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":11159,"derivative":{"exercise_price":3.5872,"underlying":"Common Shares","underlying_shares":11159},"source":{"system":"sec-edgar","filing":"0001104659-24-013529","document":"tm245827-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924013529/tm245827-2_4seq1.xml","form_type":"4"}},{"id":1651480,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-02-10T02:50:25.000Z","date":"2024-02-02","kind":"purchase","planned":false,"acquired":true,"shares":144517,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents the reference price associated with the swap agreements."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Certain Redmile Clients, including RedCo II, are parties to swap agreements with counterparties that provide those Redmile Clients with economic exposure to notional shares of the Issuer. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(cont'd) Accordingly, the Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Reporting Persons have the right to terminate and close out each swap at any time."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are directly owned by RedCo II."}],"balance_after":144517,"derivative":{"exercise_price":3.5872,"underlying":"Common Shares","underlying_shares":144517},"source":{"system":"sec-edgar","filing":"0001104659-24-013529","document":"tm245827-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924013529/tm245827-2_4seq1.xml","form_type":"4"}},{"id":1651479,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-02-10T02:50:25.000Z","date":"2024-02-01","kind":"purchase","planned":false,"acquired":true,"shares":15867,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents the reference price associated with the swap agreements."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Certain Redmile Clients, including RedCo II, are parties to swap agreements with counterparties that provide those Redmile Clients with economic exposure to notional shares of the Issuer. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(cont'd) Accordingly, the Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Reporting Persons have the right to terminate and close out each swap at any time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles and sub-advised accounts managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles and sub-advised accounts managed by Redmile, the \"Redmile Clients\"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":15867,"derivative":{"exercise_price":3.5105,"underlying":"Common Shares","underlying_shares":15867},"source":{"system":"sec-edgar","filing":"0001104659-24-013529","document":"tm245827-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924013529/tm245827-2_4seq1.xml","form_type":"4"}},{"id":1651478,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-02-10T02:50:25.000Z","date":"2024-02-01","kind":"purchase","planned":false,"acquired":true,"shares":205483,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents the reference price associated with the swap agreements."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Certain Redmile Clients, including RedCo II, are parties to swap agreements with counterparties that provide those Redmile Clients with economic exposure to notional shares of the Issuer. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(cont'd) Accordingly, the Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Reporting Persons have the right to terminate and close out each swap at any time."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are directly owned by RedCo II."}],"balance_after":205483,"derivative":{"exercise_price":3.5105,"underlying":"Common Shares","underlying_shares":205483},"source":{"system":"sec-edgar","filing":"0001104659-24-013529","document":"tm245827-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924013529/tm245827-2_4seq1.xml","form_type":"4"}},{"id":1651477,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":25414,"kind":"organization","name":"Redmile Group, LLC","position":1,"cik":"0001425738","reported_name":"Redmile Group, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25415,"kind":"person","name":"Green Jeremy","position":2,"cik":"0001650527","reported_name":"Green Jeremy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51473,"kind":"person","name":"RedCo II Master Fund, L.P.","position":3,"cik":"0001921783","reported_name":"RedCo II Master Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash-settled Swaps","published_at":"2024-02-10T02:50:25.000Z","date":"2024-02-01","kind":"other","planned":false,"acquired":false,"shares":19700,"price":3.3848,"value":66680.56,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents the reference price associated with the swap agreements."},{"field":"kind","element":"transactionCoding","label":"F9","text":"Reflects the partial settlement of an equity swap agreement entered into by and between a Redmile Client and a securities broker on December 16, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the partial settlement of an equity swap agreement entered into by and between a Redmile Client and a securities broker on December 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Certain Redmile Clients, including RedCo II, are parties to swap agreements with counterparties that provide those Redmile Clients with economic exposure to notional shares of the Issuer. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(cont'd) Accordingly, the Reporting Persons disclaim any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon settlement of the various swap agreements, either (i) the counterparty will pay to the Redmile Clients in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) the Redmile Clients will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Reporting Persons have the right to terminate and close out each swap at any time."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are directly owned by certain private investment vehicles and sub-advised accounts managed by Redmile Group, LLC (\"Redmile\"), including RedCo II Master Fund, L.P. (\"RedCo II\" and collectively with the other private investment vehicles and sub-advised accounts managed by Redmile, the \"Redmile Clients\"). Redmile may be deemed to beneficially own the reported securities as investment manager of the Redmile Clients."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green (collectively with RedCo II, the \"Reporting Persons\") disclaim beneficial ownership of the reported securities except to the extent of its and his respective pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1180136,"derivative":{"exercise_price":3.25,"underlying":"Common Shares","underlying_shares":19700},"source":{"system":"sec-edgar","filing":"0001104659-24-013529","document":"tm245827-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1425738/000110465924013529/tm245827-2_4seq1.xml","form_type":"4"}}],"next_cursor":"2024-02-10T02:50:25.000000Z,1651477"}